4.5 Article

Polycation liposomes as a vector for potential intracellular delivery of microRNA

期刊

JOURNAL OF GENE MEDICINE
卷 15, 期 10, 页码 375-383

出版社

WILEY-BLACKWELL
DOI: 10.1002/jgm.2744

关键词

drug delivery system; endosomal escape; intracellular distribution; liposomes; microRNA (miRNA)

资金

  1. Japan Society for the Promotion of Science

向作者/读者索取更多资源

BackgroundWe previously developed a microRNA (miRNA) delivery system by using dicetyl phosphate-tetraethylenepentamine-based polycation liposomes (TEPA-PCL), applied it to miR-92a delivery, and demonstrated its gene-silencing potential and effective anti-angiogenic effects. In the present study, we investigated the mechanism of intracellular delivery of cholesterol-grafted miR-92a (miR-92a-C) into cells. MethodsTo investigate the intracellular distribution of miR-92a-C/TEPA-PCL complex, we used human umbilical vein endothelial cells and examined certain points after transfection: (i) the time-course of miR-92a-uptake into the cells; (ii) the endocytosis pathway induced by miR-92a-C/TEPA-PCL; (iii) the capability of miR-92a-C/TEPA-PCL to escape from the endosomes; and (iv) the release of miR-92a-C from TEPA-PCL in the cytoplasm. ResultsOur data indicated that miR-92a-C formulated in TEPA-PCL accumulated in and was spread throughout the cytoplasm in a time-dependent manner, and was taken up into the cells by macropinosome-mediated endocytosis. In addition, the surface charge of miR-92a-C/TEPA-PCL was neutral at pH7.4 and was charged positively at around pH5.5, which is the inner pH of endosomes. When the late endosomes/lysosomes were stained with Lysotracker, miR-92a-C/TEPA-PCL efficiently escaped from the endosomes into the cytoplasm, possibly through the proton-sponge effect. Furthermore, miR-92a-C spread throughout whole cytoplasm and did not co-localize completely with TEPA-PCL, indicating that some of the miR-92a-C was present in free form in the cytoplasm. ConclusionsThe results of the present study suggest that TEPA-PCL-based lipoplexes have an excellent potential to deliver microRNAs into the cytoplasm of cells and to induce RNA silencing action mediated by microRNAs and other small RNAs. Copyright (c) 2013 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Nanoscience & Nanotechnology

Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin

Hiroyuki Koide, Tomohiro Asai, Hiroki Kato, Norihito Yonenaga, Masafumi Yokota, Hidenori Ando, Takehisa Dewa, Mamoru Nango, Noriyuki Maeda, Naoto Oku

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)

Article Biotechnology & Applied Microbiology

Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy

Hidenori Ando, Ayaka Okamoto, Masafumi Yokota, Kosuke Shimizu, Tomohiro Asai, Takehisa Dewa, Naoto Oku

JOURNAL OF GENE MEDICINE (2013)

Article Chemistry, Medicinal

Treatment of PTEN-Null Breast Cancer by a Synthetic Lethal Approach Involving PARP1 Gene Silencing

Tomohiro Asai, Masafumi Yokota, Hideki Isomura, Hiroyuki Koide, Naoyuki Sakurai, Ayaka Okamoto, Hidenori Ando, Takehisa Dewa, Naoto Oku

Summary: This study explores the synthetic lethal interaction between PTEN loss and PARP1 gene silencing in human triple-negative breast cancer cells. The delivery of siPARP1 using polycation liposomes resulted in cytotoxicity in PTEN-null MDA-MB-468 cells, but not in PTEN-positive MDA-MB-231 cells or normal cells. Simultaneous knockdown of PARP1 and PTEN inhibited cell growth in MDA-MB-231 cells. Furthermore, PARP1 knockdown led to increased DNA breaks and apoptosis in MDA-MB-468 cells compared to MDA-MB-231 cells. These findings suggest that synthetic lethality via PARP1 gene silencing holds promise for the treatment of PTEN-null breast cancer.

JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

暂无数据